| Name | Cvs Pharmacy #08611 |
|---|---|
| Organization Name | American Drug Stores Delaware Llc |
| Location | 1520 20th Ave Sw, Minot, North Dakota 58701 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (701) 852-3289 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
As the countdown for the new year begins, so does the race for the first baby of the new year. "The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of the Loyola University Health System.
Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.
Bristol-Myers Squibb Company and AbbVie today announced that the U.S. Food and Drug Administration (FDA) has granted elotuzumab, an investigational humanized monoclonal antibody, Breakthrough Therapy Designation for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have received one or more prior therapies.
› Verified 7 days ago
| NPI Number | 1700828993 |
| Organization Name | AMERICAN DRUG STORES DELAWARE LLC |
| Doing Business As | CVS PHARMACY #08611 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1520 20th Ave Sw, Minot, ND 58701 |
| Phone Number | 701-852-4068 |
News Archive
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
As the countdown for the new year begins, so does the race for the first baby of the new year. "The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of the Loyola University Health System.
Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.
Bristol-Myers Squibb Company and AbbVie today announced that the U.S. Food and Drug Administration (FDA) has granted elotuzumab, an investigational humanized monoclonal antibody, Breakthrough Therapy Designation for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have received one or more prior therapies.
› Verified 7 days ago
News Archive
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
As the countdown for the new year begins, so does the race for the first baby of the new year. "The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of the Loyola University Health System.
Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.
Bristol-Myers Squibb Company and AbbVie today announced that the U.S. Food and Drug Administration (FDA) has granted elotuzumab, an investigational humanized monoclonal antibody, Breakthrough Therapy Designation for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have received one or more prior therapies.
› Verified 7 days ago
Cvs Pharmacy #08611 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1520 20th Ave Sw, Minot, North Dakota 58701 Phone: (701) 852-3289 | |
Market Pharmacy Type: Community/Retail Pharmacy Location: 1930 S Broadway, Minot, North Dakota 58701 Phone: (701) 839-8883 | |
Key Care Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 Burdick Expy E, Minot, North Dakota 58701 Phone: (701) 857-7900 | |
B And B Northwest Pharmacy Type: Pharmacy Location: 20 Burdick Expy W, Minot, North Dakota 58701 Phone: (701) 838-2213 | |
Keycare Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 530 20th Ave Sw, Minot, North Dakota 58701 Phone: (701) 857-7370 |